• 제목/요약/키워드: Lymphoma, T-cell, cutaneous

검색결과 18건 처리시간 0.026초

Treatment of primary cutaneous anaplastic large cell lymphoma

  • Baik, Bong Soo;Lee, Wu Seop;Ji, So Young;Park, Ki Sung;Yang, Wan Suk;Kim, Sun Young
    • 대한두개안면성형외과학회지
    • /
    • 제20권3호
    • /
    • pp.207-211
    • /
    • 2019
  • Primary cutaneous anaplastic large cell lymphoma (C-ALCL) is a rare subtype of primary cutaneous lymphoma with a favorable prognosis. Primary cutaneous CD30+ lymphoproliferative disorders, which include C-ALCL and lymphomatoid papulosis, are the second most common group of cutaneous T-cell lymphomas. C-ALCL is comprised of large cells with anaplastic, pleomorphic, or immunoblastic cytomorphology, and indeed, more than 75% of the tumor cells express the CD30 antigen. C-ALCL clinically presents with solitary or localized reddish-brown nodules or tumors, and sometimes indurated papules, and they may be with ulceration covering with dark eschar. Multifocal lesions are seen in 20% of the patients. Extracutaneous dissemination, which mainly involves the regional lymph nodes, occurs in 10% of patients. A 69-year-old man noticed a mild elevated cutaneous lesion containing central ulceration covering with brownish black necrotic tissue on the right lower lip, and the lesion was surgically removed. After the first operation, another skin lesion was developed and the histological examination confirmed the diagnosis, C-ALCL. Eight specimens were excised during the 7-month follow-up period. The patient started the treatment with low-dose oral methotrexate (15 mg/wk) and there was no recurrence for 11 months.

외과적 치료 없이 관해된 피부 역형성 대세포 림프종 1예 (A Case of Multifocal Primary Cutaneous Anaplastic Large Cell Lymphoma Managed without Surgical Treatment)

  • 임준호;박언주;은석찬
    • 대한두경부종양학회지
    • /
    • 제35권2호
    • /
    • pp.77-80
    • /
    • 2019
  • Primary cutaneous anaplastic large cell lymphoma (C-ALCL) is rare among skin malignancies. C-ALCL usually manifests as reddish or violet nodules. Surgical excision or radiation therapy is generally considered as first-line therapy, but a clinically aggressive disease may require multiagent chemotherapy. Establishing a proper diagnosis of C-ALCL is challenging but should be made to avoid inappropriate treatment and its consequences. The authors report a case of medically resolved C-ALCL in an 81-year-old man presented with well-defined nodular lesions on the forehead.

Low Dose Ultraviolet Al (340-400 nm) Phototherapy for Erythrodermic Cutaneous T-cell Lymphoma

  • Uede, Koji;Hiroi, Akihisa;Nakamura, Tomoyuki;Kishi, Tomoo;Yamamoto, Yuki;Furukawa, Fukumi
    • Journal of Photoscience
    • /
    • 제9권2호
    • /
    • pp.503-505
    • /
    • 2002
  • Three patients suffering from widespread erythrodermic cutaneous T-cell lymphoma were treated with low-dose UVAI phototherapy with a single dose of 20 - 30J/$cm^2$, resulting in cumulative doses of 520 - 1890 J/$cm^2$. Two patients showed complete responses, while other had a partial improvement.

  • PDF

Cutaneous epitheliotropic T-cell lymphoma with Sézary syndrome in a dog

  • Lee, Song in;Lee, Han Joon;Seo, Kyoungwon;Song, Kunho
    • 한국동물위생학회지
    • /
    • 제44권4호
    • /
    • pp.309-313
    • /
    • 2021
  • A 12-year-old, spayed female, Toy-poodle dog presented in progressive, pruritic carpal mass and mandibular papule. The skin lesions and enlarged superficial lymph nodes were surgically removed. According to histopathology and immunohistochemistry, the patient diagnosed as cutaneous epitheliotropic T-cell lymphoma with lymph node metastasis. Chemotherapy with L-asparaginase, lomustine and prednisolone was initiated. The patient deteriorated despite treatment and was admitted to the hospital. Blood tests revealed significant leukocytosis. Circulating large lymphocytes with convoluted and cerebriform nuclei seen in peripheral blood led to presumption of Sézary cells. Thus, considering skin, lymph nodes and blood involvement, Sézary syndrome was diagnosed.

Non-epitheliotropic Cutaneous T-cell lymphoma in a cat: a case report

  • Jeon, YeSeul;Bae, Hyeona;Shin, Sun Woo;Cho, ARom;Kim, Young Ju;Hwang, Tae Sung;Lee, Hee Chun;Hyun, Jae-Eun;Cho, Kyu-Woan;Jung, Dong-In;Kim, Dae-Yong;Yu, DoHyeon
    • 대한수의학회지
    • /
    • 제62권2호
    • /
    • pp.13.1-13.5
    • /
    • 2022
  • Cutaneous lymphoma is rare in cats. An 11-year-old spayed female Persian cat presented with crust, ulceration, and multiple nodules on the shoulder and forelimb for 2 months. Computed tomography revealed a diffuse, irregularly margined lesion in the dorsal cutis extending from cervical to thoracic vertebrae. Cytological evaluation predominantly revealed large round cells with multilobulated nuclei and basophilic cytoplasm. Histopathological examination confirmed round CD3+/PAX5-cells packed in the dermis. Thus, the diagnosis of non-epitheliotropic cutaneous lymphoma with a diffuse large T-cell type was made. The disease progressed rapidly for the next 2 weeks, and the owner elected humane euthanasia.

Primary cutaneous CD4+ small/medium T-cell lymphoma: a case report

  • Kim, Jeenam;Jeong, Minkyoung;Jun, Dongkeun;Lee, Myungchul;Shin, Donghyeok;Kim, Wookyoun;Choi, Hyungo
    • 대한두개안면성형외과학회지
    • /
    • 제22권4호
    • /
    • pp.199-203
    • /
    • 2021
  • Primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder is a rare disease characterized by a single mass on the face or upper part of the trunk. It usually presents an asymptomatic and favorable progression, and its histopathologic findings include small and medium-sized lymphoid cells. The authors report a case of primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder on the forehead. A 51-year-old man presented with a protruding mass on his forehead that the patient had noted 1 month previously. Surgical excision and a permanent biopsy were performed under local anesthesia. Based on the biopsy results, the mass was diagnosed as a primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder. There was no evidence of recurrence at a 15-month follow-up visit.

Metabolomics Investigation of Cutaneous T Cell Lymphoma Based on UHPLC-QTOF/MS

  • Zhou, Qing-Yuan;Wang, Yue-Lin;Li, Xia;Shen, Xiao-Yan;Li, Ke-Jia;Zheng, Jie;Yu, Yun-Qiu
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제15권13호
    • /
    • pp.5417-5421
    • /
    • 2014
  • Objectives: The identification of cutaneous T cell lymphoma (CTCL) biomarkers may serve as a predictor of disease progression and treatment response. The aim of this study was to map potential biomarkers in CTCL plasma. Design and Methods: Plasma metabolic perturbations between CTCL cases and healthy individuals were investigated using metabolomics and ultrahigh performance liquid chromatography-quadrupole time-of-flight mass spectrometry (UHPLC-QTOF/MS). Results: Principal component analysis (PCA) of the spectra showed clear metabolic changes between the two groups. Thirty six potential biomarkers associated with CTCL were found. Conclusions: Based on PCA, several biomarkers were determined and further identified by LC/MS/MS analysis. All of these could be potential early markers of CTCL. In addition, we established that heparin as a nticoagulant has better pre-treatment results than EDTA with the UHPLC-QTOF/MS appraoch.

Peripheral Blood Lymphocytosis without Bone Marrow Infiltration in a Dog with T-Zone Lymphoma

  • YeSeul Jeon;Hyeona Bae;DoHyeon Yu
    • 한국임상수의학회지
    • /
    • 제40권3호
    • /
    • pp.203-208
    • /
    • 2023
  • A 13-year-old neutered male mixed-breed dog presented with generalized lymphadenopathy and erythematous cutaneous lesions in the ear pinnae. Fine-needle aspiration cytology of the lymph nodes revealed small to intermediate lymphocytes with a "hand mirror" configuration as the predominant cell type. Histopathological analysis of the lymph node showed an infiltrate of CD3-positive small lymphocytes compressing the follicles against the capsule owing to neoplastic cell expansion. Flow cytometric analysis revealed a homogeneous population of CD3+/CD4-/CD5+/CD8-/CD21+/CD34-/CD45- cells in both the peripheral blood and aspirated lymph nodes, which supports the diagnosis of T-zone lymphoma. Laboratory tests revealed lymphocytosis (14,144 cells/µL) in the peripheral blood. However, contrary to expectations, the bone marrow examination revealed no evidence of lymphocytic infiltration. T-zone lymphoma is an indolent lymphoma with a long survival period, and knowledge of its characteristics may affect disease staging and prognosis evaluation. Therefore, peripheral blood count as a sole screening tool for bone marrow metastasis should be used with caution.

피부 T 세포림프종의 전 피부 전자선 치료를 위한 dosimetry 연구 (A Study on the Dosimetry of the Total Skin Electron Beam Therapy in Cutaneous T-Cell Lymphoma)

  • 신교철;윤형근
    • 한국의학물리학회지:의학물리
    • /
    • 제7권2호
    • /
    • pp.57-65
    • /
    • 1996
  • 피부 T 세포림프종에 대하여 4MeV 의 전자선으로 전 피부 방사선 조사를 시행하였다. 피부전체의 균일한 선량분포를 위하여 스탠포드대학의 방법으로 알려져 있는 six dual field 기법을 사용하였다. SSD 는 390cm로 하였으며 방사선 조사시의 gantry 의 각은 환자의 중심을 지나는 수평축에 대하여 상ㆍ하로 14$^{\circ}$가 되도록 하였다. 전자콘을 설치해야만 전자선 조사가 가능하므로 최대의 전자콘인 25$\times$25cm콘을 사용하였다. 치료면에서의 선량분포의 균일성을 확인하기 위하여 치료면에 90$\times$180cm의 폴리스틸렌을 설치하고 Famer type ion chamber와 측정용 필름을 사용하여 측정하였다. 그 결과 치료면에서 10% 정도의 균일함을 보였다. 환자의 자세를 하루에 세가지씩 이틀에 걸쳐 여섯가지 자세를 한 주기로 치료를 시행하였다. 선량이 부족한 정수리, 회음부, 발바닥 등은 따로 추가의 방사선을 조사하였다. 렌즈와 손톱, 발톱은 차폐물을 제작하여 차폐하였다.

  • PDF

개에서 발생한 피부 상피친화성 T-세포 림프종: Lomustine 및 Gemcitabine에 대한 임상적 반응 (Cutaneous Epitheliotropic T-Cell Lymphoma in a Dog: Clinical Responses to Lomustine and Gemcitabine)

  • 강병택;김대영;강지훈;장동우;정동인;조규완;양만표
    • 한국임상수의학회지
    • /
    • 제30권4호
    • /
    • pp.315-319
    • /
    • 2013
  • 5년령의 중성화된 암컷 말티즈가 1개월 동안 지속된 전신적 발적, 탈모 및 소양감으로 내원하였다. 피부조직구증으로 진단되어 면역억제치료를 1개월 간 지속하였지만 다발성의 발적된 반 및 판 병변들이 새롭게 발생하였다. 피부병변에 대한 압박도말검사에서 림프종을 지시하는 원형세포들이 관찰되었다. 조직학적 검사에서는 종양세포들의 외피 및 부속구조물에 대한 친화성이 나타났다. 면역염색결과 종양세포들은 CD3에 대하여 양성, CD79a에 대해서는 음성반응을 나타내어 피부 상피친화성 T-세포 림프종으로 확진하였다. $70mg/m^2$의 lomustine을 2-3주 간격으로 총 2회 투여하였으며 부분적인 치료반응이 관찰되었다. 피부병변의 악화와 lomustine의 이용제한으로 gemcitabine ($500mg/m^2$, 1주일당 1회 30분간 혈관주입)을 이용한 화학치료를 시작하였다. 총 3회 치료가 실시되었으나 질병의 진행을 억제하지 못하였으며, 최초 lomustine 치료 69일 후 안락사 되었다.